IRVINE, Calif. (AP) _ Edwards Lifesciences Corp. (EW) on Tuesday reported fourth-quarter profit of $398.4 million.
On a per-share basis, the Irvine, California-based company said it had net income of 65 cents. Earnings, adjusted for one-time gains and costs, were 64 cents per share.
The results beat Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of 61 cents per share.
The medical device maker posted revenue of $1.35 billion in the period, also exceeding Street forecasts. Eleven analysts surveyed by Zacks expected $1.33 billion.
For the year, the company reported profit of $1.52 billion, or $2.44 per share. Revenue was reported as $5.38 billion.
For the current quarter ending in March, Edwards Lifesciences expects its per-share earnings to range from 58 cents to 64 cents.
The company said it expects revenue in the range of $1.37 billion to $1.45 billion for the fiscal first quarter.
Edwards Lifesciences expects full-year earnings in the range of $2.45 to $2.60 per share, with revenue ranging from $5.6 billion to $6 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a EW">Zacks stock report on EW at https://www.zacks.com/ap/EW